EMA — authorised 2 March 2004
- Status: approved
EMA authorised Advate on 2 March 2004
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 2 March 2004.
Marketing authorisation holder not available in our data.